The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Small Animals Respiratory Diseases Treatment Market Research Report 2024
Synopsis
According to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks.
The global Small Animals Respiratory Diseases Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 21%.
This report aims to provide a comprehensive presentation of the global market for Small Animals Respiratory Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Animals Respiratory Diseases Treatment.
Report Scope
The Small Animals Respiratory Diseases Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Animals Respiratory Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Animals Respiratory Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis, Inc.
Merck Animal Health
Boehringer Ingelheim GmbH
Bayer AG
Ceva Animal Health
Vetoquinol SA
Virbac Ltd.
Segment by Type
Anthelmintics
Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Antibiotics
Antihistamines
Phosphodiesterase (PDE) inhibitors
Bronchodilators
Antineoplastic Agents
Segment by Application
Allergic Pneumonitis
Canine Influenza
Canine Nasal Mites
Lung Nematodes
Neoplasia Of Respiratory System
Pneumonia
Rhinitis And Sinusitis
Tonsilitis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Animals Respiratory Diseases Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
According to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks.
The global Small Animals Respiratory Diseases Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 21%.
This report aims to provide a comprehensive presentation of the global market for Small Animals Respiratory Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Animals Respiratory Diseases Treatment.
Report Scope
The Small Animals Respiratory Diseases Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Animals Respiratory Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Animals Respiratory Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis, Inc.
Merck Animal Health
Boehringer Ingelheim GmbH
Bayer AG
Ceva Animal Health
Vetoquinol SA
Virbac Ltd.
Segment by Type
Anthelmintics
Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Antibiotics
Antihistamines
Phosphodiesterase (PDE) inhibitors
Bronchodilators
Antineoplastic Agents
Segment by Application
Allergic Pneumonitis
Canine Influenza
Canine Nasal Mites
Lung Nematodes
Neoplasia Of Respiratory System
Pneumonia
Rhinitis And Sinusitis
Tonsilitis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Animals Respiratory Diseases Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Animals Respiratory Diseases Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anthelmintics
1.2.3 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Antibiotics
1.2.6 Antihistamines
1.2.7 Phosphodiesterase (PDE) inhibitors
1.2.8 Bronchodilators
1.2.9 Antineoplastic Agents
1.3 Market by Application
1.3.1 Global Small Animals Respiratory Diseases Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Allergic Pneumonitis
1.3.3 Canine Influenza
1.3.4 Canine Nasal Mites
1.3.5 Lung Nematodes
1.3.6 Neoplasia Of Respiratory System
1.3.7 Pneumonia
1.3.8 Rhinitis And Sinusitis
1.3.9 Tonsilitis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Animals Respiratory Diseases Treatment Market Perspective (2019-2030)
2.2 Small Animals Respiratory Diseases Treatment Growth Trends by Region
2.2.1 Global Small Animals Respiratory Diseases Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Small Animals Respiratory Diseases Treatment Historic Market Size by Region (2019-2024)
2.2.3 Small Animals Respiratory Diseases Treatment Forecasted Market Size by Region (2025-2030)
2.3 Small Animals Respiratory Diseases Treatment Market Dynamics
2.3.1 Small Animals Respiratory Diseases Treatment Industry Trends
2.3.2 Small Animals Respiratory Diseases Treatment Market Drivers
2.3.3 Small Animals Respiratory Diseases Treatment Market Challenges
2.3.4 Small Animals Respiratory Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Animals Respiratory Diseases Treatment Players by Revenue
3.1.1 Global Top Small Animals Respiratory Diseases Treatment Players by Revenue (2019-2024)
3.1.2 Global Small Animals Respiratory Diseases Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Small Animals Respiratory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Animals Respiratory Diseases Treatment Revenue
3.4 Global Small Animals Respiratory Diseases Treatment Market Concentration Ratio
3.4.1 Global Small Animals Respiratory Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Animals Respiratory Diseases Treatment Revenue in 2023
3.5 Small Animals Respiratory Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Small Animals Respiratory Diseases Treatment Product Solution and Service
3.7 Date of Enter into Small Animals Respiratory Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Animals Respiratory Diseases Treatment Breakdown Data by Type
4.1 Global Small Animals Respiratory Diseases Treatment Historic Market Size by Type (2019-2024)
4.2 Global Small Animals Respiratory Diseases Treatment Forecasted Market Size by Type (2025-2030)
5 Small Animals Respiratory Diseases Treatment Breakdown Data by Application
5.1 Global Small Animals Respiratory Diseases Treatment Historic Market Size by Application (2019-2024)
5.2 Global Small Animals Respiratory Diseases Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Small Animals Respiratory Diseases Treatment Market Size (2019-2030)
6.2 North America Small Animals Respiratory Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Small Animals Respiratory Diseases Treatment Market Size by Country (2019-2024)
6.4 North America Small Animals Respiratory Diseases Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Animals Respiratory Diseases Treatment Market Size (2019-2030)
7.2 Europe Small Animals Respiratory Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Small Animals Respiratory Diseases Treatment Market Size by Country (2019-2024)
7.4 Europe Small Animals Respiratory Diseases Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Animals Respiratory Diseases Treatment Market Size (2019-2030)
8.2 Asia-Pacific Small Animals Respiratory Diseases Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Small Animals Respiratory Diseases Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Small Animals Respiratory Diseases Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Animals Respiratory Diseases Treatment Market Size (2019-2030)
9.2 Latin America Small Animals Respiratory Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Small Animals Respiratory Diseases Treatment Market Size by Country (2019-2024)
9.4 Latin America Small Animals Respiratory Diseases Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Animals Respiratory Diseases Treatment Market Size (2019-2030)
10.2 Middle East & Africa Small Animals Respiratory Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Small Animals Respiratory Diseases Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Small Animals Respiratory Diseases Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis, Inc.
11.1.1 Zoetis, Inc. Company Detail
11.1.2 Zoetis, Inc. Business Overview
11.1.3 Zoetis, Inc. Small Animals Respiratory Diseases Treatment Introduction
11.1.4 Zoetis, Inc. Revenue in Small Animals Respiratory Diseases Treatment Business (2019-2024)
11.1.5 Zoetis, Inc. Recent Development
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Detail
11.2.2 Merck Animal Health Business Overview
11.2.3 Merck Animal Health Small Animals Respiratory Diseases Treatment Introduction
11.2.4 Merck Animal Health Revenue in Small Animals Respiratory Diseases Treatment Business (2019-2024)
11.2.5 Merck Animal Health Recent Development
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Detail
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Small Animals Respiratory Diseases Treatment Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Small Animals Respiratory Diseases Treatment Business (2019-2024)
11.3.5 Boehringer Ingelheim GmbH Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Detail
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Small Animals Respiratory Diseases Treatment Introduction
11.4.4 Bayer AG Revenue in Small Animals Respiratory Diseases Treatment Business (2019-2024)
11.4.5 Bayer AG Recent Development
11.5 Ceva Animal Health
11.5.1 Ceva Animal Health Company Detail
11.5.2 Ceva Animal Health Business Overview
11.5.3 Ceva Animal Health Small Animals Respiratory Diseases Treatment Introduction
11.5.4 Ceva Animal Health Revenue in Small Animals Respiratory Diseases Treatment Business (2019-2024)
11.5.5 Ceva Animal Health Recent Development
11.6 Vetoquinol SA
11.6.1 Vetoquinol SA Company Detail
11.6.2 Vetoquinol SA Business Overview
11.6.3 Vetoquinol SA Small Animals Respiratory Diseases Treatment Introduction
11.6.4 Vetoquinol SA Revenue in Small Animals Respiratory Diseases Treatment Business (2019-2024)
11.6.5 Vetoquinol SA Recent Development
11.7 Virbac Ltd.
11.7.1 Virbac Ltd. Company Detail
11.7.2 Virbac Ltd. Business Overview
11.7.3 Virbac Ltd. Small Animals Respiratory Diseases Treatment Introduction
11.7.4 Virbac Ltd. Revenue in Small Animals Respiratory Diseases Treatment Business (2019-2024)
11.7.5 Virbac Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
